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B. A. C. Dijkmans, M. I. Koolen, R. P. Mouton, T. H. M. Falke, P. J. van den Broek, 
J. W. M. van der Meer
Hematogenous Candida Vertebral Osteomyelitis Treated with 
Ketoconazole '
Summary: Candida vertebral osteomyelitis was diag­
nosed in a patient with systemic lupus erythematodes 
following X-ray evidence of osteomyelitis and the re­
peated culturing of Candida albicans from material 
obtained by needle biopsies from the third lumbar ver­
tebra. The patient had been on glucocorticosteroids and 
parenteral nutrition six months previously. At that time, 
a yeast was cultured from the blood and the tip of the 
subclavian catheter which had been removed. After 
Candida vertebral osteomyelitis was diagnosed, she was 
treated with ketoconazole for seven months. Recovery 
was impressive, as judged by the clinical and radio- 
graphic findings; At the time of writing this paper -1 2  
months after the withdrawal of ketoconazole -  the 
patient showed no signs of recurrence.
Zusammenfassung: Behandlung einer hämatogenen 
Candida-Wirbelosteomyelitis mit Ketoconazol. Bei einer 
Patientin mit systemischem Lupus erythematodes wurde 
röntgenologisch eine Wirbelosteomyelitis diagnosti­
ziert. In Material, das durch Punktur des dritten Len­
denwirbelkörpers gewonnen wurde, ließ sich kulturell 
wiederholt Candida albicans nachweisen. Sechs Monate 
vorher war die Patientin mit Kortikosteroiden behan­
delt und parenteral ernährt worden. Zu dieser Zeit 
wurden aus dem Blut und von der Spitze des entfernten 
Subclävia-Katheters Hefen kultiviert, Nachdem eine 
Wirbelosteomyelitis durch Candida diagnostiziert wor­
den war, wurde die Patientin sieben Monate lang mit 
Ketoconazol behandelt. Entsprechend den klinischen 
und röntgenologischen Befunden kam es zu einem ein­
drucksvollen Heilungsverlauf. Zwölf Monate nach 
Beendigung der Ketoconazolbehandlung -  zum Zeit­
punkt der Manuskripterstellung -  waren bei der Patien­
tin keine Zeichen für einen Rückfall festzustellen.
Introduction
Ketoconazole is a new antifungal drug which is absorbed 
from the gut after oral administration (1). The results 
obtained in vitro and in experimental animals with coc- 
cidiomycosis and histoplasmosis suggest that this is a 
potent drug (2-5). Experience in patients with serious 
fungal infections is limited, and the results are difficult to 
assess (6). Recently, we successfully used ketoconazole to 
treat a patient with a deep-seated Candida infection.
Case Report
A 30-year-old Chinese woman was admitted to our hospital in 
March 1980 with a history of backache and vomiting. Systemic 
lupus erythematodes had been tentatively diagnosed elsewhere 
in June 1979; the following September, she had been treated 
with 40 mg prednisone daily for a nephrotic syndrome in 
another hospital. During that period, the patient received 
parenteral nutrition. On September 30th, she developed fever 
and chills; a yeast was cultured from the blood and from the tip 
of the subclavian catheter which had been removed. No antifun­
gal treatment was given. The pain in the lumbar region had 
started in January 1980 and had increased steadily, irradiating to 
the right gluteal area. During the last few days prior to admis­
sion, she had been vomiting. She had lost 5 kg bodyweight in 
the previous two weeks.
Physical examination revealed a thin, severely ill woman. She 
weighed 44 kg and was 160 cm tall. Her temperature was 37° C, 
pulse rate 64/min and blood pressure 130/70 mmHg. There was 
slight facial and pretibial edema. The abdomen was swollen and 
the peristalsis weak. On palpation, the abdomen was diffusely 
tender. Rectal examination disclosed no abnormalities. A slight 
swelling was observed on the back to the right of L2. There was 
percussion pain over L3-L4 and pain at axial pressure. On 
admisson, the erythrocyte sedimentation rate was 68 mm in the 
first hour (Westergren). The patient had mild anemia: hemoglo­
bin was 7.3 mmol/1 and hematocrit 39%. The white cell count 
was 6.7 x 109/1 with normal differentiation; the thrombocyte 
count was 80 x 109/l. Renal function was severely impaired 
(serum creatinine:85 |xmol/l; creatinine clearance; 30 ml/min) 
and a nephrotic syndrome was present (serum protein concen­
tration; 52 g/1; serum albumin; 19 g/1; urinary protein excretion: 
8-22 g/day).
Systemic lupus erythematodes was diagnosed on the basis of 
proteinuria, thrombocytopenia, strongly positive antinuclear 
antibodies, a positive LE cell phenomenon (class Y. A) and a 
history of pleurisy of unknown cause.
The complement profile was in accordance with this diagnosis: 
C3: 0.20 g/1 (normal: 0.55-0.73); C4: 0.05 g/1 (0.16-0.27); Clq: 
0.53 gfl (0.94-1.22); and CH50: 54 U/ml (185-261).
A lateral tomogram of the lumbar vertebral column showed the 
typical changes found in spondylitis (Figure 1). The intravenous 
pyelogram showed displacement of the right ureter and defor­
mation of the right psoas outline by a paravertebral mass
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Figure 1: Lateral tomogram of the lumbar spine showing 
sclerosis and cortical destruction of the third vertebral 
body. Soft tissue calcifications can be seen, with the bridg­
ing of a narrowed interspace.
Figure 2: Intravenous pyelography. Tomographic section 
through the kidneys shows displacement of the right ureter 
and deformation of the right psoas outline by a paraverte­
bral mass.
(Figure 2). Computer tomography of the lumbar region con­
firmed these findings (Figure 3a). A gallium scan revealed 
increased uptake in the L2-L3 area with extension toward the 
right side. Enteroclytic examination of the small bowel revealed 
swollen mucosal folds in the terminal ileum.
The third lumbar vertebra was punctured twice; Gram staining 
showed yeasts on both occasions, and Candida albicans was 
cultured from the material punctured. The strain was sensitive 
to ketoconazole. Exposure to a concentration of 0.1 |ig/ml 
ketoconazole in Sabouraud broth resulted in inhibition of >50% 
after 14 days (7). Complete inhibition only occurred with 
ketoconazole concentrations of ^  16 ¡ig/ml. When the strain was 
cultured in Eagle’s minimal essential medium (EMEM) with 
10% fetal calf serum, pseudomycelia formation was completely 
inhibited at concentrations of <  0.008 |Ag/ml ketoconazole (8). 
We diagnosed Candida vertebral osteomyelitis with inflamma­
tion of the surrounding structures, probably due to hematogen­
ous spread. The intestinal abnormalities were attributed to a 
reflectory mechanism. Because of impaired renal function, the 
administration of amphotericin B was considered to be too 
hazardous. On April 14th, treatment with miconazole was 
started (600 mg i. v. once daily). After seven days, the patient 
refused further intravenous therapy, and ketoconazole (400 mg 
per os four times daily) was started on April 22nd. Serum 
concentrations of the drug, which were determined microbiolog- 
ically as described elsewhere (9), were low, even at this high 
dose (Table 1). Withdrawing the antacid drug improved resorp­
tion slightly, but the concomitant administration of 15 ml of
Table 1: Serum concentrations of ketoconazole.
Time*
(h)
D uring antacid 
therapy 
(mg/1)
W ithout
antacid
(mg/1)
W ith hydro­
chloric acid 
(mg/1)
1 1.1 2.3 1.6
2 1.2 2.1 7.1
3 N .D . 1.3 6.1
4 0.2 N .D . 3.2
8 <  0.2 N .D . 0.7
* after administration 
N .D . =  not determined
Figure 3: CT scan of the third vertebral body at the level of 
the intervertebral foramen.
Figure 3a: Before treatment: inflammatory swelling of the 
right psoas with thickening of Gerota’s fascia. Marginal 
destruction of the vertebral body and soft tissue calcifica­
tions.
Figure 3b: After treatment: the right psoas is normal in size.
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0.03 mol/1 hydrochloric acid solution produced much higher 
levels of ketoconazole in the serum (Table 1).
Despite increased activity of the underlying illness, the clinical 
condition (pain, vomiting) related to the osteomyelitis and the 
soft tissue inflammation improved dramatically. After seven 
months of therapy, there were no signs of active infection, and a 
computerized tomogram showed that the right psoas was normal 
in size (Figure 3b); ketoconazole was therefore withdrawn in 
November 1980. Follow-up to the time of writing (November 
1981) revealed no evidence of recurrence.
Discussion
Although Candida species are frequently implicated in 
systemic and local infections, they are seldom mentioned 
as etiologic agents of osteomyelitis (10). As far as we 
know, only eight well-documented cases of vertebral 
osteomyelitis due to Candida species have been reported 
(11-16). The most important factors predisposing to sys­
temic Candida infection in these patients were 
hyperalimentation, previous use of antibiotics, bowel 
surgery and heroin addiction.
Three of the patients reported to have Candida vertebral 
osteomyelitis were treated with amphotericin B , two were 
treated with amphotericin B combined with 5-flucytosine,
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